Ads
related to: merck pharmaceuticals
Search results
Pharma Stock Roundup: BAYRY's Q1 Earnings, JNJ's New Buyout, Pipeline Updates
Zacks via Yahoo Finance· 1 hour agoMerck MRK will discontinue the Keytruda plus vibostolimab co-formulation arm of a phase III melanoma...
The Zacks Analyst Blog Highlights Broadcom, Merck, Airbnb, ONEOK and PG&E
Zacks via Yahoo Finance· 1 day agoHowever, it expects flat growth in the wireless segment. (You can read the full research report on...
Profit down at German pharmaceutical firm Merck in first quarter
dpa international via Yahoo Finance· 2 days agoProfit after income tax at German pharmaceutical firm Merck declined 12.5% to €699 million ($756.9...
Merck (MRK) Ends Keytruda Combo Melanoma Study Due to Futility
Zacks via Yahoo Finance· 3 days agoAs the study failed to reach superiority for the DFS endpoint, its other primary endpoint of overall...
Check Out What Whales Are Doing With MRK - Merck & Co (NYSE:MRK)
Benzinga· 22 hours agoWithin cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial...
Who Is Kristen Welker's Husband? All About John Hughes
People Magazine· 3 days agoKristen Welker and her husband, John Hughes, have another baby on the way! The Meet the Press host...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks via Yahoo Finance· 1 day agoLooking at individual holdings, Axsome Therapeutics Inc (AXSM) accounts for about 4.81% of total...
Merck cancels trial of melanoma treatment due to immune-mediated adverse events
Clinical Trials Arena via Yahoo Finance· 3 days agoUS pharmaceutical company Merck & Co Inc (MSD) has discontinued a Phase III trial investigating a...
Meet Kristen Welker's husband, John Hughes
The US Sun· 3 days agoNBC moderator Kristen Welker switched careers when she was named to take over Chuck Todd's position as the new Meet the Press host. With Welker's career...
Merck KGaA’s Q1 adjusted profit declines less than feared
WSAU Wausau· 2 days agoBy Ludwig Burger FRANKFURT (Reuters) - Merck KGaA on Wednesday reported better-than-expected...